RxDoctor Payments Data

Peter Park, MD

Vascular & Interventional Radiology · Old Bridge, NJNPI 1487609723

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,369 of the $8,330 with a category attached, or 64.5%. It is spread thinly across 26 manufacturers, the largest accounting for just 22.7%.

$8,330in general payments, 2019–2025

Across 122 payments — averaging $68.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Biosense Webster, Inc.$2K
  • Nevro Corp.$914
  • Boston Scientific$751
  • Medtronic$731
  • Philips North America LLC$436
  • plus $2K from 20 others

What the payments were for

  • Speaking & faculty fees$4075%
  • Travel & lodging$2,55431%
  • Food & beverage$5,36964%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,330 in reported general payments places this provider in the 80th percentile of 111 vascular & interventional radiology providers in New Jersey.

See all vascular & interventional radiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$1,642,129
Medicare patients
265
Services billed
2,011

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban31$15,565
ClopidogrelClopidogrel Bisulfate62$379
Lidocaine-PrilocaineLidocaine/Prilocaine11$145

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Old Bridge

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →